Thc Therapeutics, Inc. (THCT) SEC Filing 8-K Material Event for the period ending Wednesday, June 26, 2019

Thc Therapeutics, Inc.

CIK: 827876 Ticker: THCT

View differences made from one to another to evaluate Thc Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Thc Therapeutics, Inc..


Assess how Thc Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Thc Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: THCT
CIK: 1404935
Form Type: 8-K Corporate News
Accession Number: 0001477932-19-003864
Submitted to the SEC: Tue Jul 02 2019 4:30:12 PM EST
Accepted by the SEC: Tue Jul 02 2019
Period: Wednesday, June 26, 2019
Industry: Farm Machinery And Equipment
  1. Ending Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: